Related Experiment Videos
Staging and managing lung tumors using F-18 FDG coincidence detection.
M R Roman1, M A Rossleigh, S Angelides
1Department of Nuclear Medicine, The Prince of Wales & Sydney Children's Hospitals, Sydney, New South Wales 2031, Australia.
Clinical Nuclear Medicine
|April 24, 2001
Summary
Fluorine-18 fluorodeoxyglucose (F-18 FDG) coincidence positron emission tomography (co-PET) is a reliable tool for staging lung neoplasms. This imaging technique accurately identifies primary tumors, lymph node involvement, and distant spread, influencing patient management.
Area of Science:
- Nuclear Medicine
- Oncology
- Radiology
Background:
- Fluorine-18 fluorodeoxyglucose (F-18 FDG) positron emission tomography (PET) is crucial for evaluating and staging pulmonary neoplasms.
- Coincidence PET (co-PET) imaging has recently been introduced into clinical practice.
Purpose of the Study:
- To assess the efficacy of co-PET in identifying primary lung tumors.
- To evaluate co-PET's accuracy in detecting mediastinal lymph node involvement.
- To determine the impact of co-PET on disease staging and management decisions.
Main Methods:
- Prospective study involving 60 patients with 61 lung tumors.
- Histopathologic confirmation was obtained for 58 patients (59 tumors).
- Co-PET imaging was used to assess primary lesions, lymph nodes, and distant spread.
Main Results:
- Co-PET demonstrated high accuracy for primary lesions (95%) and lymph node involvement (91%).
- Previously unknown distant metastases were identified in 8 patients; 5 false-positive brain lesions were noted.
- Disease staging was altered in 33% of patients, and management plans were changed in 33% based on co-PET findings.
- Unnecessary surgery was avoided in 10% of patients, and one patient received curative treatment.
Conclusions:
- F-18 FDG co-PET imaging is a reliable method for evaluating patients with lung neoplasms.
- The findings suggest co-PET significantly impacts clinical decision-making in lung cancer management.
- Co-PET offers valuable diagnostic information for staging and treatment planning.